| Filed On | Filing |
|---|---|
| 12 Nov 2026 | FORM 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
Conference call to discuss financial and operational results scheduled for |
| 12 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 10, 2026, Singapore Volition Pte. Limited (“Singapore Volition”), a wholly-owned subsidiary of VolitionRx Limited (the “Company”), and Mr. Cameron Reynolds, Chief Executive Officer and President of the Company, entered into a... |
| 27 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
This Waiver and Consent (this “Waiver”) is entered into effective as of October 23, 2026 (the “Waiver Date”), by and between Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lender” or “Holder”), and VolitionR... |
| 23 Oct 2026 |
Form 4: Batchelor Ann-Louise, Group Chief Marketing Officer
Received 12,000 shares as a grant or award |
| 30 Sep 2026 |
Form 4: Forterre Gael, Chief Commercial Officer
Gave up 284 shares to cover exercise price or tax ($71.8) |
| 30 Sep 2026 |
Form 4: Michel Gaetan, Chief Operating Officer
Gave up 608 shares to cover exercise price or tax ($154) |
| 25 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC,... |
| 16 Sep 2026 | SCHEDULE 13D/A |
| 15 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC,... |
| 14 Sep 2026 |
8-K: Other Events
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 |
| 09 Sep 2026 | EFFECT |
| 09 Sep 2026 | FORM S-3/A |
| 08 Sep 2026 | FORM S-3/A |
| 04 Sep 2026 | SCHEDULE 13D |
| 02 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
This WAIVER AND CONSENT (this “Waiver and Consent”) is dated as of September 2nd, 2026 (the “Effective Date”), by and between VolitionRx Limited, a Delaware corporation (the “Company” or “Maker”), and Lind Global Asset Management XII LLC... |
| 02 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC,... |
| 28 Aug 2026 | FORM S-3 |
| 24 Aug 2026 |
8-K: Unregistered Sales of Equity Securities
As previously reported, pursuant to that certain securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026, the “SPA”), VolitionRx Limited (the “Company”) issued to Lind Global Asset Management XII LLC,... |
| 21 Aug 2026 | FORM S-8 |
Loading...